Healthpeak Properties Inc. Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? Healthpeak Properties Inc. Common Stock trades at $18.61 (market cap $12.77B), while Zimmer Biomet Holdings Inc trades at $89.31 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and Healthpeak Properties Inc. Common Stock pays the higher dividend (6.59%). Which is the better fit depends on your goals — on Pluang, investors hold Healthpeak Properties Inc. Common Stock for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| DOC | ZBH | |
|---|---|---|
Market Cap | $12.77B | $16.95B |
Volume | 11,021,809 | 2,505,240 |
Sector | Real Estate | Health |
52-Week High | $22.82 | $103.98 |
52-Week Low | $15.78 | $79.58 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $21.46B | $24.02B |
Dividend Yield | 6.59% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.
The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Healthpeak Properties is a healthcare real estate investment trust in the United States. It owns, operates, and develops outpatient medical, laboratory, and senior housing properties.
Read more on DOC →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →